PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

340B

340B policy, covered-entity economics, contract pharmacy disputes, and channel implications for manufacturers and access teams.

1 article·Lives underPolicy Commercialization·Last updated 2026-05-27

Policy· May 27, 2026 · 12 min read

Medicare Transaction Facilitator guide for manufacturers: MFP effectuation workflow, pharmacy and manufacturer enrollment, data exchange, and launch access implications

By Ran Chen#Medicare Part D #IRA Negotiation #Payer Policy